Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new safety module, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 July 2026, 13:00 (CEST) to 23 July 2026, 14:30 (CEST)

Clinical Trials Information System (CTIS) bitesize talk: Annual safety report (ASR) new safety module, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 23 July 2026, 13:00 (CEST) to 23 July 2026, 14:30 (CEST)

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Apremilast Accord, apremilast, Date of authorisation: 19/04/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Posaconazole Accord, posaconazole, Date of authorisation: 25/07/2019, Revision: 13, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – June 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2026, 16:30 (CEST) to 12 June 2026, 17:30 (CEST)

Product Management Service (PMS) public API beta release - Technical overview and live demo, Online, from 13 July 2026, 14:00 (CEST) to 13 July 2026, 15:30 (CEST)

Product Management Service (PMS) public API beta release - Technical overview and live demo, Online, from 13 July 2026, 14:00 (CEST) to 13 July 2026, 15:30 (CEST)

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): LysaKare, arginine,lysine, Date of authorisation: 25/07/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Anktiva, nogapendekin alfa inbakicept, Date of authorisation: 16/02/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Anktiva, nogapendekin alfa inbakicept, Date of authorisation: 16/02/2026, Revision: 1, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.